Sign up to save your podcasts
Or
Share Can differences in T1 Relaxivity between Gadolinium-based contrast agents be taken advantage of to lower the administered dose of gadolinium?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Can differences in T1 Relaxivity between Gadolinium-based contrast agents be taken advantage of to lower the administered dose of gadolinium?
Full article: https://www.ajronline.org/doi/abs/10.2214/AJR.21.25924
Intracranial deposition of gadolinium after contrast-enhanced MRI is an emerging area of concern with much still to be learned. Kalen Riley, MD, MBA discusses a new article that proposes a dose-reduction strategy that takes advantage of relatively higher T1 relaxivity of one macrocyclic agent compared to another while still striving to maintain an adequate imaging examination.
View all episodes
By AJR
4.6
4545 ratings
Full article: https://www.ajronline.org/doi/abs/10.2214/AJR.21.25924
Intracranial deposition of gadolinium after contrast-enhanced MRI is an emerging area of concern with much still to be learned. Kalen Riley, MD, MBA discusses a new article that proposes a dose-reduction strategy that takes advantage of relatively higher T1 relaxivity of one macrocyclic agent compared to another while still striving to maintain an adequate imaging examination.
More shows like AJR Podcasts
View all
Fresh Air
38,470 Listeners
Planet Money
30,686 Listeners
The NPR Politics Podcast
25,887 Listeners
Marketplace
8,715 Listeners
WSJ What’s News
4,365 Listeners
Radiology Podcast | RSNA
89 Listeners
AJNR Podcasts
28 Listeners
The Daily
112,362 Listeners
Up First from NPR
56,459 Listeners
The Indicator from Planet Money
9,533 Listeners
Today, Explained
10,233 Listeners
RadioGraphics Podcast | RSNA
30 Listeners
The Radiology Review Podcast
204 Listeners
The Ezra Klein Show
16,145 Listeners
The Radiopaedia Reading Room Podcast
42 Listeners